What's New
Bug fix...
Bug fix...
Size:
3.3 MB
Category:
Medical
Medical
OS:
iOS
iOS
Price:
$9.99
$9.99
Compatible:
iPhone iPad
iPhone iPad
Requirements:
Requires iOS 6.0 or la
Requires iOS 6.0 or la
Version:
1.0
1.0
Description - AKPO Managing toxicities of new oral anticancer agents
Brouard Benoit , the publisher behind many iOS app (AKPO : Gestion des effets indésirables des chimiothérapies orales ,AKPO Managing toxicities of new oral anticancer agents ,InfectioGuide ,Risque SIDA ,InfectioGuide Gratuit ,eBlood gas), brings AKPO Managing toxicities of new oral anticancer agents with a number of new features along with the usual bug fixes. AKPO Managing toxicities of new oral anticancer agents app has been update to version 1.0 with several major changes and improvements. App release that improves performance, provides several new options.
.
If you are iPhone and iPad owner,you now can download AKPO Managing toxicities of new oral anticancer agents for $9.99 from Apple Store. The application is supporting English language. It weighs in at only 3.3 MB to download. The new AKPO Managing toxicities of new oral anticancer agents app version 1.0 has been updated on 2015-01-28. The Apple Store includes a very useful feature that will check if your device and iOS version are both compatible with the app. Most iPhone and iPad are compatible. Here is the app`s compatibility information: Requires iOS 6.0 or later. Compatible with iPhone, iPad, and iPod touch. This app is optimized for iPhone 5.
Bottom Line: For more information about AKPO Managing toxicities of new oral anticancer agents check developer Brouard Benoit`s website : http://www.appphone.fr
Bottom Line: For more information about AKPO Managing toxicities of new oral anticancer agents check developer Brouard Benoit`s website : http://www.appphone.fr
New targeted agents have the same frequency and severity of toxicities as traditional cytotoxic agents, with the difference being the nature of the toxic effects. Thus, the classical chemotherapy toxicities (vomiting, myelosuppression, mucositis, nausea, and ...
